The epidemiology of multiple sclerosis: insights to a causal cascade

Handbook of Clinical Neurology

Volumn 138, Issue , 2016, Pages 173-206

  Goodin, D S ^a  

^a UCSF Multiple Sclerosis Center   (United States)

Author keywords

cause; disease course; environment; Epstein Barr; gender; genetics; infection; natural history; obesity; pathogenesis; pregnancy; smoking; stress; susceptibility; trauma; virus; vitamin D

Indexed keywords

FEMALE; GENETIC PREDISPOSITION; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; MALE; MULTIPLE SCLEROSIS; PREVALENCE; RISK FACTOR;

FEMALE; GENE-ENVIRONMENT INTERACTION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MULTIPLE SCLEROSIS; PREVALENCE; RISK FACTORS;

EID: 84999633528     PISSN: 00729752     EISSN: 22124152     Source Type: Book Series    
DOI: 10.1016/B978-0-12-802973-2.00011-2     Document Type: Chapter

References (229)

1. Ackerman, K., Relationship between multiple sclerosis exacerbations and stress. Psychosom Med 66 (2004), 288–289.
2. Ackerman, K.D., Heyman, R., Rabin, B.S., et al. Stressful life events precede exacerbations of multiple sclerosis. Psychosom Med 64 (2002), 916–920.
3. Ackerman, K.D., Stover, A., Heyman, R., et al. Relationship of cardiovascular reactivity, stressful life events, and multiple sclerosis disease activity. Brain Behav Immun 17 (2003), 141–151.
4. Adams, C.W.M., A Colour Atlas of Multiple Sclerosis and Other Myelin Disorders. 1989, Wolfe Medical Publications, Ipswich, Suffolk, UK, 101.
5. Ahmad, T., Neville, M., Marshall, S.E., et al. Haplotype-specific linkage disequilibrium patterns. Hum Mol Genet 12 (2003), 647–656.
6. Alotaibi, S., Kennedy, J., Tellier, R., et al. Epstein–Barr virus in pediatric multiple sclerosis. JAMA 291 (2004), 1875–1879.
7. Alter, M., Yamoor, M., Harshe, M., Multiple sclerosis and nutrition. Arch Neurol 31 (1974), 267–272.
8. Alter, M., Kahana, E., Loewenson, R., Migration and risk of multiple sclerosis. Neurology 28 (1978), 1089–1093.
9. Andersen, O., Lygner, P.E., Bergstrom, T., et al. Viral infections trigger multiple sclerosis relapses: a prospective seroepidemiological study. J Neurol 240 (1993), 417–422.
10. Antonovsky, A., Leibowitz, U., Smith, H.A., et al. Epidemiological study of multiple sclerosis in Israel. I. An overall review of methods and findings. Arch Neurol 13 (1965), 183–193.
11. Ascherio, A., Munger, K.L., Environmental risk factors for multiple sclerosis. Part I: The role of infection. Ann Neurol 61 (2007), 288–299.
12. Ascherio, A., Munger, K.L., Epidemiology of multiple sclerosis: from risk factors to prevention – an update. Semin Neurol 36 (2016), 103–114.
13. Ascherio, A., Munger, K.L., Lennette, E.T., et al. Epstein–Barr virus antibodies and the risk of multiple sclerosis: a prospective study. Am Med Assoc J 286 (2001), 3083–3088.
14. Bager, P., Nielsen, N.M., Bihrmann, K., et al. Sibship characteristics and risk of multiple sclerosis: a nationwide cohort study in Denmark. Am J Epidemiol 163 (2006), 1112–1117.
15. Bagos, P.G., Ioannidid, Nikolopoulos, A., Chlamydia pneumoniae infection and the risk of multiple sclerosis: a meta-analysis. Mult Scler 12 (2006), 397–411.
16. Baranzini, S.E., Wang, J., Gibson, R.A., et al. Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. Hum Mol Genet 18 (2009), 767–778.
17. Barnett, M.H., William, D.B., Day, S., et al. Progressive increase in incidence and prevalence of multiple sclerosis in Newcastle, Australia: a 35-year study. J Neurol Sci 213 (2003), 1–6.
18. Bar-Or, A., Oliviera, E.M.L., Anderson, D.E., et al. Molecular pathogenesis of multiple sclerosis. J Neuroimmunol 100 (1999), 252–259.
19. Bartolomei, M.S., Tilghman, S.M., Genomic imprinting in mammals. Annu Rev Genet 31 (1997), 493–525.
20. Bø, L., Vedeler, C.A., Nyland, H.I., et al. Subpial demyelination in the cerebral cortex of multiple sclerosis patients. J Neuropathol Exp Neurol 62 (2003), 723–732.
21. Brain, R., Wilkinson, M., The association of cervical spondylosis and disseminated sclerosis. Brain 80 (1957), 456–478.
22. Bray, P.F., Bloomer, L.C., Salmon, V.C., et al. Epstein–Barr virus infection and antibody synthesis in patients with multiple sclerosis. Arch Neurol 40 (1983), 406–408.
23. Buljevac, D., Hop, W.C.J., Reedeker, W., et al. Self reported stressful life events and exacerbations in multiple sclerosis: prospective study. Br Med J 327 (2003), 646–651.
24. Cabre, P., Signate, A., Olindo, S., et al. Role of return migration in the emergence of multiple sclerosis in the French West Indies. Brain 128 (2005), 2899–2910.
25. Cantorna, M.T., Vitamin D and autoimmunity: is vitamin D status an environmental factor affecting autoimmune disease prevalence?. Proc Soc Exp Biol Med 223 (2000), 230–233.
26. Cantorna, M.T., Mahon, B.D., Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence. Exp Biol Med 229 (2004), 1136–1142.
27. Celius, E.G., Vandvik, B., Multiple sclerosis in Oslo, Norway: prevalence on 1 January 1995 and incidence over a 25-year period. Eur J Neurol 8 (2001), 463–469.
28. Chaudhuri, A., Why we should offer routine vitamin D supplementation in pregnancy and childhood to prevent multiple sclerosis. Med Hypotheses 64 (2005), 608–618.
29. Chaudhuri, M.D., Behan, P.O., Acute cervical hyperextension-hyperflexion injury may precipitate and/or exacerbate symptomatic multiple sclerosis. Eur J Neurol 8 (2001), 659–664.
30. Compston, A., Coles, A., Multiple sclerosis. Lancet 359 (2002), 1221–1231.
31. Compston, A., Confavreux, C., Lassmann, H., et al. McAlpine's Multiple Sclerosis. 4th edn., 2006, Churchill Livingstone, London.
32. Confavreux, C., Vukusic, S., Natural history of multiple sclerosis: a unifying concept. Brain 129 (2006), 606–616.
33. Confavreux, C., Hutchinson, M., Hours, M.M., et al. Rate of pregnancy-related relapse in multiple sclerosis. N Engl J Med 339 (1998), 285–291.
34. Confavreux, C., Vukusic, S., Adeleine, P., Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process. Brain 126 (2003), 770–782.
35. Conlon, P., Oksenberg, J.R., Zhang, J., et al. The immunobiology of multiple sclerosis: an autoimmune disease of the central nervous system. Neurobiol Dis 6 (1999), 149–166.
36. Correale, J., Peirano, I., Romano, L., Benign multiple sclerosis: a new definition of this entity is needed. Mult Scler 18 (2012), 210–218.
37. Da Silva, K.R.P., Papais, R.P., Fernandez y Fernandez, O., et al. Potenciais fatores de risco para o desenvolvimento de esclerose multipla no Rio de Janeiro: um estudo caso controle. Arq Neuropsiquiatr 67 (2009), 229–234.
38. De Jager, P.L., Jia, X., Wang, J., et al. Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci. Nature Genet 41 (2009), 776–782.
39. Dean, G., Kurtzke, J.F., On the risk of multiple sclerosis according to age at immigration to South Africa. Br Med J 3 (1971), 725–729.
40. Deluca, H.F., Cantorna, M.T., Vitamin D: Its role and uses in immunology. FASEB J 15 (2001), 2579–2585.
41. Dikson, S.P., Wang, K., Krantz, I., et al. Rare variants create synthetic genome-wide associations. PLoS Biol, 8(1), 2010, e1000294.
42. Dyment, D.A., Yee, I.M.L., Ebers, G.C., et al. Multiple sclerosis in stepsiblings: recurrence risk and ascertainment. J Neurol Neurosurg Psychiatry 77 (2006), 258–259.
43. Ebers, G., Multiple sclerosis, stress and the rules of evidence. Practical Neurol 4 (2004), 66–69.
44. Ebers, G.C., Sadovnick, A.D., Risch, N.J., et al. A genetic basis for familial aggregation in multiple sclerosis. Nature 377 (1995), 150–151.
45. Ebers, G.C., Yee, I.M.L., Sandovnick, A.D., et al. Conjugal multiple sclerosis: population-based prevalence and recurrence risks in offspring. Ann Neurol 48 (2000), 927–931.
46. Ebers, G.C., Sadovnick, A.D., Dyment, D.A., et al. Parent-of-origin effect in multiple sclerosis: observations in half-siblings. Lancet 363 (2004), 1773–1774.
47. Edwards, S., Zvartau, M., Clarke, H., et al. Clinical relapses and disease activity on magnetic resonance imaging associated with viral upper respiratory tract infections in multiple sclerosis. J Neurol Neurosurg Psychiatry 64 (1998), 736–741.
48. Elian, M., Nightingale, S., Dean, G., Multiple sclerosis among United Kingdom-born children of immigrants from the Indian subcontinent, Africa, and the West Indies. J Neurol Neurosurg Psychiatry 53 (1990), 906–911.
49. Emmons, K.M., Colditz, G.A., Preventing excess sun exposure: it is time for a national policy. J Natl Cancer Inst 91 (1999), 1269–1270.
50. Engelhardt, S., Patkar, S., Ogunshola, O.O., Cell-specific blood–brain barrier regulation in health and disease: a focus on hypoxia. Br J Pharmacol 171 (2014), 1210–1230.
51. Engell, T., A clinical patho-anatomical study of clinically silent multiple sclerosis. Acta Neurol Scand 79 (1989), 428–430.
52. Estruch, R., Ros, E., Salas-Salvadó, J., et al. Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med 368 (2013), 1279–1290.
53. Evans, K.N., Nguyen, L., Chan, J., et al. Effects of 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 on cytokine production by human decidual cells. Biol Reprod 75 (2006), 816–822.
54. Farrell, P.J., Role for HLA in susceptibility to infectious mononucleosis. J Clin Invest 117 (2007), 2756–2758.
55. Ferguson, B., Matyszak, M.K., Esiri, M.M., et al. Axonal damage in acute multiple sclerosis lesions. Brain 120 (1997), 393–399.
56. Fiddes, B., Wason, J., Kemppinen, A. et al., Confounding underlies the apparent month of birth effect in multiple sclerosis. Ann Neurol 73 (2013), 714–720.
57. Fiddes, B., Wason, J., Sawcer, S., Confounding in association studies: month of birth and multiple sclerosis. J Neurol 261 (2014), 1851–1856.
58. Filippi, M., Rocca, M.A., Martino, G. et al., Magnetization transfer changes in the normal appearing white matter precede the appearance of enhancing lesions in patients with multiple sclerosis. Ann Neurol 43 (1998), 809–814.
59. Fisher, E., Rudick, R.A., Simon, J.H., et al. Eight-year follow-up study of brain atrophy in patients with MS. Neurology 59 (2002), 1412–1420.
60. Fisniku, L.K., Brex, P.A., Altmann, D.R., et al. Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis. Brain 131 (2008), 808–817.
61. Fitzgerald, G., Harbige, L.S., Forti, A., et al. The effect of nutritional counseling on diet and plasma EFA status in multiple sclerosis patients over 3 years. Hum Nutr Appl Nutr 41A (1987), 297–310.
62. Freedman, D.M., Mustafa, M., Alavanja, M.C.R., Mortality from multiple sclerosis and exposure to residential and occupational solar radiation: a case-control study based on death certificates. Occup Environ Med 57 (2000), 418–421.
63. French Research Group on Multiple Sclerosis, Multiple sclerosis in 54 twinships: concordance rate is independent of zygosity. Ann Neurol 32 (1992), 724–727.
64. Gadoth, N., Review article: Multiple sclerosis in children. Brain Dev 25 (2003), 229–232.
65. Georgi, V.W., Multiple Sklerose: Pathologisch-Anamtomische Befunde multiple Sklerose bei klinisch nicht diagniostizierte Krankbeiten. Schweiz Med Wochenschr 20 (1966), 605–607.
66. Ghadirian, P., Jain, M., Ducic, S., et al. Nutritional factors in the aetiology of multiple sclerosis: a case-control study in Montreal, Canada. Int J Epidemiol 27 (1998), 845–852.
67. Gianfrancesco, M.A., Acuna, B., Shen, L., et al. Obesity during childhood and adolescence increases susceptibility to multiple sclerosis after accounting for established genetic and environmental risk factors. Obes Res Clin Pract 8:5 (2014), e435–e447.
68. Gilbert, J., Sadler, M., Unsuspected multiple sclerosis. Arch Neurol 40 (1983), 533–536.
69. Gillie, O., A new government policy is needed for sunlight and vitamin D. Br J Dermatol 154 (2006), 1052–1061.
70. Goodkin, D.E., Rooney, W.D., Sloan, R. et al., A serial study of new MS lesions and the white matter from which they arise. Neurology 51 (1998), 1689–1697.
71. Golan, D., Somer, E., Dishon, S., et al. The impact of exposure to war stress on exacerbations of multiple sclerosis. Ann Neurol 64 (2008), 143–149.
72. Goldacre, M.J., Wotton, C.J., Seagroatt, V., et al. Multiple sclerosis after infectious mononucleosis: record linkage study. J Epidemiol Community Health 58 (2004), 1032–1035.
73. Goldacre, M.J., Abisgold, J.D., Yeates, D.G.R., et al. Risk of multiple sclerosis after head injury: record linkage study. J Neurol Neurosurg Psychiatry 277 (2006), 351–353.
74. Goodin, D.S., Perils and pitfalls in the interpretation of clinical trials: a reflection on the recent experience in multiple sclerosis. Neuroepidemiology 18 (1999), 53–63.
75. Goodin, D.S., Relationship between multiple sclerosis exacerbations and stress. Psychosom Med 66 (2004), 287–288.
76. Goodin, D.S., The causal cascade to multiple sclerosis: a model for MS pathogenesis. PLoS One, 4, 2009, e4565.
77. Goodin, D.S., The nature of genetic susceptibility to multiple sclerosis: constraining the possibilities. BMC Neurol, 16(1), 2016, 56.
78. Goodin, D.S., Khankhanian, P., Single nucleotide polymorphism (SNP)-strings: an alternative method for assessing genetic associations. PLoS One, 9(4), 2014, e90034.
79. Goodin, D.S., Ebers, G.C., Johnson, K.P., et al. The relationship of MS to physical trauma and psychological stress: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 52 (1999), 1737–1745.
80. Goodin, D.S., Jones, J., Li, D., et al. Establishing long-term efficacy in chronic disease: the use of recursive partitioning and propensity score adjustment to estimate long-term outcome in multiple sclerosis. PLoS One, 6(11), 2011, e22444.
81. Gourraud, P.A., Harbo, H.F., Hauser, S.L., et al. The genetics of multiple sclerosis: an up-to-date review. Immunol Rev 248 (2012), 87–103.
82. Griffin, M.D., Lutz, W., Phan, V.A., et al. Dendritic cell modulation by 1-alpha,25 dihydroxyvitamin D3 and its analogs: a vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo. Proc Natl Acad Sci 98 (2001), 6800–6805.
83. Grønlie, S.A., Myrvoll, E., Hansen, G., et al. Multiple sclerosis in North Norway, and first appearance in an indigenous population. J Neurol 247 (2000), 129–133.
84. Gronseth, G.S., Ashman, E.J., Practice parameter: the usefulness of evoked potentials in identifying clinically silent lesions in patients with suspected multiple sclerosis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 54 (2000), 1720–1725.
85. Haahr, S., Plesner, A.M., Vestergaard, B.F., et al. A role of late Epstein–Barr virus infection in multiple sclerosis. Acta Neurol Scand 109 (2004), 270–275.
86. Hansen, T., Skytthe, A., Stenager, E., et al. Risk for multiple sclerosis in dizygotic and monozygotic twins. Mult Scler 11 (2005), 500–503.
87. Hansen, T., Skytthe, A., Stenager, E., et al. Concordance for multiple sclerosis in Danish twins: an update of a nationwide study. Mult Scler 11 (2005), 504–510.
88. Harel-Meir, M., Sherer, Y., Shoenfeld, Y., Tobacco smoking and autoimmune rheumatic diseases. Nat Clin Pract Rheumatol 3 (2007), 707–715.
89. Hauser, S.L., Oksenberg, J.R., The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration. Neuron 52 (2006), 61–76.
90. Hawkins, S.A., McDonnell, G.V., Benign multiple sclerosis? Clinical course, long term follow up, and assessment of prognostic factors. J Neurol Neurosurg Psychiatry 67 (1999), 148–152.
91. Hayes, C.E., Nashold, F.E., Spach, K.M., et al. The immunological functions of the vitamin D endocrine system. Cell Molec Biol 49 (2003), 277–300.
92. Hedström, A.K., Olsson, O., Alfredsson, L., High body mass index before age 20 is associated with increased risk for multiple sclerosis in both men and women. Mult Scler 18 (2012), 1334–1336.
93. Henle, W., Henle, G., Andersson, J., et al. Antibody responses to Epstein–Barr virus-determined nuclear antigen (EBNA)-1 and EBNA-2 in acute and chronic Epstein–Barr virus infection. Proc Natl Acad Sci U S A 84 (1987), 570–574.
94. Hernán, M.A., Olek, M.J., Ascherio, A., Geographic variation of MS incidence in two prospective studies of US women. Neurology 53 (1999), 1711–1718.
95. Hernán, M.A., Olek, M.J., Ascherio, A., Cigarette smoking and incidence of multiple sclerosis. Am J Epidemiol 154 (2001), 69–74.
96. Hernán, M.A., Jick, S.S., Logroscino, G., et al. Cigarette smoking and the progression of multiple sclerosis. Brain 128 (2005), 1461–1465.
97. Herrera, B.M., Ramagopalan, S.V., Orton, S., et al. Parental transmission of MS in a population-based Canadian cohort. Neurology 69 (2007), 1208–1212.
98. Hofker, M.H., Fu, J., Wijmenga, C., The genome revolution and its role in understanding complex diseases. Biochim Biophys Acta 1842 (2014), 1889–1895.
99. Holick, M.F., Vitamin D requirements for humans of all ages: new increased requirements for women and men 50 years and older. Osteoporos Int 8:Suppl 2 (1998), S24–S29.
100. Holman, D.W., Klein, R.S., Ransohoff, R.M., The blood–brain barrier, chemokines and multiple sclerosis. Biochim Biophys Acta 1812 (2011), 220–230.
101. Housley, W.J., Pitt, D., Hafler, D.A., Biomarkers in multiple sclerosis. Clin Immunol 161 (2015), 51–58.
102. Houtchens, M.K., Pregnancy and multiple sclerosis. Semin Neurol 27 (2007), 434–441.
103. International Multiple Sclerosis Genetics Consortium (IMSGC), Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat Genet 45 (2014), 1353–1360.
104. International Multiple Sclerosis Genetics Consortium and the Wellcome Trust Case Control Consortium, Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 476 (2011), 214–219.
105. Islam, T., Gauderman, W.J., Cozen, W., et al. Differential twin concordance for multiple sclerosis by latitude of birthplace. Ann Neurol 60 (2006), 56–64.
106. Jablonski, N.G., Chaplin, G., The evolution of human skin coloration. J Hum Evol 39 (2000), 57–106.
107. Jablonski, N.G., Chaplin, G., Skin deep. Sci Am 287 (2002), 74–81.
108. Kahana, E., Zilber, N., Abramson, J.H., et al. Multiple sclerosis: genetic versus environmental aetiology: epidemiology in Israel updated. J Neurol 241 (1994), 341–346.
109. Kantarci, O.H., Barcellos, L.F., Atkinson, E.J., et al. Men transmit MS more often to their children vs women: the Carter effect. Neurology 67 (2006), 305–310.
110. Kaufman, M., Gaydos, C.A., Sriram, S., et al. Is Chlamydia pneumoniae found in spinal fluid samples from multiple sclerosis patients? Conflicting results. Mult Scler 8 (2002), 289–294.
111. Khankhanian, P., Gourraud, P.A., Lizee, A., et al. Haplotype-based approach to known MS-associated regions increases the amount of explained risk. J Med Genet 52:9 (2015), 587–594.
112. Kimlin, M.G., Olds, W.J., Moore, M.R., Location and vitamin D synthesis: is the hypothesis validated by geophysical data?. J Photochem Photobiol B Biol 86 (2007), 234–239.
113. Kip, K.E., Cohen, F., Cole, S.R., et al. Recall bias in a prospective cohort study of acute time-varying exposures: example from the herpetic eye disease study. J Clin Epidemiol 54 (2001), 482–487.
114. Koch-Henderson, N., Multiple sclerosis in Scandinavia and Finland. Acta Neurol Scand 161 (1995), 55–59.
115. Koch-Henriksen, N., The Danish Multiple Sclerosis Registry: a 50-year follow-up. Mult Scler 5 (1999), 293–296.
116. Kremenchutsky, M., Rice, G.P.A., Baskerville, D.M., et al. The natural history of multiple sclerosis: a geographically based study 9: observations on the progressive phase of the disease. Brain 129 (2006), 584–594.
117. Kroencke, D.C., Denney, D.R., Stress and coping in multiple sclerosis: exacerbation, remission and chronic subgroups. Mult Scler 5 (1999), 89–93.
118. Krone, B., Pohl, D., Rostasy, K., et al. Common infectious agents in multiple sclerosis: a case–control study in children. Mult Scler 14 (2008), 136–139.
119. Kuusisto, H., Kaprio, J., Kinnunen, E., et al. Concordance and heritability of multiple sclerosis in Finland: study on a nationwide series of twins. Eur J Neurol 15 (2008), 1106–1110.
120. Larsen, P.D., Bloomer, L.C., Bray, P.F., Epstein–Barr nuclear antigen and viral capsid antigen antibody titers in multiple sclerosis. Neurology 35 (1985), 435–438.
121. Lee, J.Y., Chitnis, T., Pediatric multiple sclerosis. Semin Neurol 36 (2016), 148–153.
122. Levin, L.I., Munger, K.L., Rubertone, M.V., et al. Temporal relationship between elevation of Epstein–Barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis. Am Med Assoc J 293 (2005), 2496–2500.
123. Li, J., Johansen, C., Brønnum-Hansen, H., et al. The risk of multiple sclerosis in bereaved parents: a nationwide cohort study in Denmark. Neurology 62 (2004), 726–729.21.
124. Liguori, M., Marrosu, M.G., Pugliatti, M., et al. Age at onset in multiple sclerosis. Neurol Sci 21 (2000), S825–S829.
125. Lips, P., Vitamin D physiology. Prog Biophys Molec Biol 92 (2006), 4–8.
126. Lublin, F.D., Reingold, S.C., Cohen, J.A., et al. Defining the clinical course of multiple sclerosis: the 2013 revisions. Neurology 83 (2014), 278–286.
127. Lucchinetti, C.F., Popescu, B.F., Bunyan, R.F., et al. Inflammatory cortical demyelination in early multiple sclerosis. N Engl J Med 365 (2011), 2188–2197.
128. Makhani, N., Banwell, B., Tellier, R., et al. Viral exposures and MS outcome in a prospective cohort of children with acquired demyelination. Mult Scler 22 (2016), 385–388.
129. McIntosh, A.M., Holmes, S., Gleeson, S., et al. Maternal recall bias, obstetric history and schizophrenia. Br J Psychiatry 181 (2002), 520–525.
130. Merelli, E., Casoni, F., Prognostic factors in multiple sclerosis: role of intercurrent infections and vaccinations against influenza and hepatitis B. Neurol Sci 21 (2000), S853–S856.
131. Mikaeloff, Y., Caridade, G., Tardieu, M., et al. Parental smoking at home and the risk of childhood-onset multiple sclerosis in children. Brain 130 (2007), 2589–2595.
132. Mohr, D.C., Goodkin, D.E., Bacchetti, P., et al. Psychological stress and the subsequent appearance of new brain lesions in MS. Neurology 55 (2003), 55–61.
133. Moll, N.M., Cossoy, M.B., Fisher, E., et al. Imaging correlates of leukocyte accumulation and CXCR4/CXCL12 in multiple sclerosis. Arch Neurol 66 (2009), 44–53.
134. Montgomery, S.M., Bahmanyar, S., Hillert, J., et al. Maternal smoking during pregnancy and multiple sclerosis amongst offspring. Eur J Neurol 15 (2008), 1398–1402.
135. Moses, H., Sriram, S., An infectious basis for multiple sclerosis: perspectives on the role of Chlamydia pneumoniae and other agents. Bio Drugs 15 (2001), 199–206.
136. Müller, A.M.S., Ihorst, G., Mertelsmann, R., et al. Epidemiology of non-Hodgkin's lymphoma (NHL): trends, geographic distribution, and etiology. Ann Hematol 84 (2005), 1–12.
137. Mumford, C.J., Wood, N.W., Kellar-Wood, H., et al. The British Isles survey of multiple sclerosis in twins. Neurology 44 (1994), 11–15.
138. Munch, M., Riisom, K., Christensen, T., et al. The significance of Epstein–Barr virus seropositivity in multiple sclerosis patients?. Acta Neurol Scand 97 (1998), 171–174.
139. Munger, K.L., DeLorenze, G.N., Levin, L.I., et al. A prospective study of Chlamydia pneumoniae infection and risk of MS in two US cohorts. Neurology 62 (2004), 1799–1803.
140. Munger, K.L., Zhang, S.M., O'Reilly, E., et al. Vitamin D intake and incidence of multiple sclerosis. Neurology 62 (2004), 60–65.
141. Munger, K.L., Levin, L.I., Hollis, B.W., et al. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. Am Med Assoc J 296 (2006), 2832–2838.
142. Munger, K.L., Chitnis, T., Ascherio, A., Body size and risk of MS in two cohorts of US women. Neurology 73 (2009), 1543–1550.
143. Munger, K.L., Bentzen, J., Laursen, B., et al. Childhood body mass index and multiple sclerosis risk: a long-term cohort study. Mult Scler 19 (2013), 1323–1329.
144. Muoio, V., Persson, P.B., Sendeski, M.M., The neurovascular unit – concept review. Acta Physiol 210 (2014), 790–798.
145. Myhr, K.M., Riise, T., Barrett-Connor, E., et al. Altered antibody pattern to Epstein–Barr virus but not to other herpesviruses in multiple sclerosis: a population based case-control study from western Norway. J Neurol Neurosurg Psychiatry 164 (1998), 539–542.
146. Nagpal, S., Na, S., Rathnachalam, R., Noncalcemic actions of vitamin D receptor ligands. Endocr Rev 26 (2005), 662–687.
147. Nielsen, N.M., Westergaard, T., Rostgaard, K., et al. Familial risk of multiple sclerosis: a nationwide cohort study. Am J Epidemiol 162 (2005), 774–778.
148. Nielsen, T.R., Rostgaard, K., Nielsen, N.M., et al. Multiple sclerosis after infectious mononucleosis. Arch Neurol 64 (2007), 72–75.
149. Nisipeanu, P., Korczyn, A.D., Psychological stress as risk factor for exacerbations in multiple sclerosis. Neurology 43 (1993), 1311–1312.
150. O'Riordan, J.I., Thompson, D.P., Kingsley, D.P., et al. The prognostic value of brain MRI in clinically isolated syndromes of the CNS. a 10-year follow-up. Brain 121 (1998), 495–503.
151. Okuda, D.T., Mowry, E.M., Beheshtian, A., et al. Incidental MRI anomalies suggestive of multiple sclerosis: the radiologically isolated syndrome. Neurology 72 (2009), 800–805.
152. Okuda, D.T., Mowry, E.M., Cree, B.A., et al. Asymptomatic spinal cord lesions predict disease progression in radiologically isolated syndrome. Neurology 76 (2011), 686–692.
153. Okuda, D.T., Siva, A., Kantarci, O., et al. Radiologically isolated syndrome: 5-year risk for an initial clinical event. PLoS One, 9(3), 2014, e90509.
154. Oppenheimer, D.R., The cervical cord in multiple sclerosis. Neuropathol Appl Neurobiol 4 (1978), 151–162.
155. Optic Neuritis Study Group, Multiple sclerosis risk after optic neuritis: final optic neuritis treatment trial follow-up. Arch Neurol 65 (2008), 727–732.
156. Orton, S.M., Herrera, B.M., Yee, I.M., et al. Sex ratio of multiple sclerosis in Canada: a longitudinal study. Lancet Neurol 5 (2006), 932–936.
157. Padyukov, L., Silva, C., Stolt, P., et al. A gene–environment interaction between smoking and shared epitope genes in HLA–DR provides a high risk of seropositive rheumatoid arthritis. Arthritis Rheum 50 (2004), 3085–3092.
158. Panitch, H.S., Influence of infection on exacerbations of multiple sclerosis. Ann Neurol 36 (1994), S25–S28.
159. Parratt, J., Tavendale, R., O'Riordan, J., et al. Chlamydia pneumoniae-specific serum immune complexes in patients with multiple sclerosis. Mult Scler 14 (2008), 292–299.
160. Peterson, J.W., Bø, L., Mørk, S., et al. Transected neurites, apoptotic neurons and reduced inflammation in cortical MS lesions. Ann Neurol 50 (2001), 389–400.
161. Pittock, S.J., Mayr, W.T., McClelland, R.L., et al. Disability profile of MS did not change over 10 years in a population-based prevalence cohort. Neurology 62 (2004), 601–606.
162. Pohl, D., Krone, B., Rostasy, K., et al. High seroprevalence of Epstein–Barr virus in children with multiple sclerosis. Neurology 67 (2006), 2063–2065.
163. Ponsonby, A.L., van der Mei, Dwyer, T., et al. Exposure to infant siblings during early life and risk of multiple sclerosis. Am Med Assoc J 293 (2005), 463–469.
164. Ramagopalan, S.V., Maugeri, N.J., Handunnetthi, L., et al. Expression of the multiple sclerosis-associated MHC class II allele HLA-DRB1*1501 is regulated by vitamin D. PLoS Genet, 5(2), 2009, e1000369.
165. Ranzato, F., Perini, P., Tzintzeva, E., et al. Increasing frequency of multiple sclerosis in Padova, Italy: a 30 year epidemiological survey. Mult Scler 9 (2003), 387–392.
166. Riise, T., Nortvedt, M.W., Ascherio, A., Smoking is a risk factor for multiple sclerosis. Neurology 61 (2003), 1122–1124.
167. Ristori, G., Cannoni, S., Stazi, M.A., et al. Multiple sclerosis in twins from continental Italy and Sardinia: a nationwide study. Ann Neurol 59 (2006), 27–34.
168. Robertson, N.P., Fraser, M., Deans, J., et al. Age-adjusted recurrence risks for relatives of patients with multiple sclerosis. Brain 119 (1996), 449–455.
169. Rodríguez Regal, A., del Campo Amigo, M., Paz-Esquete, J., et al. Estudio de casos y controles sobre la influencia del hábito tabáquico en la esclerosis multiple. Neurologia 24 (2009), 177–180.
170. Rodriguez, M., Siva, A., Cross, S., et al. Optic neuritis: a population based study in Olmsted county, Minnesota. Neurology, 44, 1994, A374.
171. Rosati, G., The prevalence of multiple sclerosis in the world: an update. Neurol Sci 22 (2001), 117–139.
172. Rosenbaum, P.R., Rubin, D.B., The central role of propensity score in observational studies for causal effects. Biometrika 70 (1983), 41–55.
173. Rothman, K.J., Greenland, S., Modern Epidemiology. 2nd edn., 1998, Lippincott Williams & Wilkins, Philadelphia, PA.
174. Ruggieri, M., Polizzi, A., Pavone, L., et al. Multiple sclerosis in children under 6 years of age. Neurology 53 (1999), 478–484.
175. Runmarker, B., Andersen, O., Prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of follow-up. Brain 116 (1993), 117–134.
176. Sadovnick, A.D., Ebers, G.C., Dyment, D.A., et al. Evidence for genetic basis of multiple sclerosis. Lancet 347 (1996), 1728–1730.
177. Sadovnick, A.D., Yee, I.M.L., Ebers, G.C., et al. Multiple sclerosis and birth order: a longitudinal cohort study. Lancet Neurol 4 (2005), 611–617.
178. Sadovnick, A.D., Duquette, P., Herrera, B., et al. A timing-of-birth effect on multiple sclerosis clinical phenotype. Neurology 69 (2007), 60–62.
179. Salemi, G., Callari, G., Gammino, M., et al. The relapse rate of multiple sclerosis changes during pregnancy: a cohort study. Acta Neurol Scand 110 (2004), 23–26.
180. Sarasoja, T., Wikström, J., Paltamaa, J., et al. Occurrence of multiple sclerosis in central Finland: a regional and temporal comparison during 30 years. Acta Neurol Scand 110 (2004), 331–336.
181. Scalfari, A., Neuhaus, A., Degenhardt, A. et al., The natural history of multiple sclerosis: a geographically based study 10: relapses and long-term disability. Brain 133 (2010), 1914–1929.
182. Sepcic, J., Mesaros, E., Materljan, E., et al. Nutritional factors and multiple sclerosis in Gorski Kotar, Croatia. Neruoepidemiology 12 (1993), 234–240.
183. Serafini, B., Roiscarelli, B., Franciotta, D., et al. Dysregulated Epstein–Barr virus infection in multiple sclerosis. J Exp Med 204 (2007), 2899–2912.
184. Sharief, M.K., Thompson, E.J., The predictive value of intrathecal immunoglobulin synthesis and magnetic resonance imaging in acute isolated syndromes for subsequent development of multiple sclerosis. Ann Neurol 29 (1991), 147–151.
185. Shirodaria, P.V., Haire, M., Fleming, E., et al. Viral antibody titers: comparison in patients with multiple sclerosis and rheumatoid arthritis. Arch Neurol 144 (1987), 1237–1241.
186. Sibley, W.A., Bamford, C.R., Clark, K., Clinical viral infections and multiple sclerosis. Lancet 1:8441 (1985), 1313–1315.
187. Sinclair, H., Polyunsaturated fatty acids in multiple sclerosis. Br Med J, 2, 1977, 1217.
188. Spach, K.M., Hayes, C.E., Vitamin D3 confers protection from autoimmune encephalomyelitis only in female mice. J Immunol 175 (2005), 4119–4126.
189. Spitzer, C., Bouchain, M., Winkler, L.Y., et al. Childhood trauma in multiple sclerosis: a case-control study. Psychosom Med 74 (2012), 312–318.
190. Staples, J., Ponsonby, A.L., Lim, L., Low maternal exposure to ultraviolet radiation in pregnancy, month of birth and risk of multiple sclerosis in offspring: a longitudinal analysis. Br Med J, 340, 2010, c1640.
191. Suarez, F., Rossignol, C., Garabédian, M., Interactive effect of estradiol and vitamin D receptor gene polymorphisms as a possible determinant of growth in male and female infants. J Clin Endocrinol Metab 83 (1998), 3563–3568.
192. Sumaya, C.V., Myers, L.W., Ellison, G.W., Epstein–Barr virus antibodies in multiple sclerosis. Arch Neurol 37 (1980), 94–96.
193. Sumaya, C.V., Myers, L.W., Ellison, G.W., et al. Increased prevalence and titer of Epstein–Barr virus antibodies in patients with multiple sclerosis. Ann Neurol 17 (1985), 371–377.
194. Sundström, P., Nyström, L., Forsgren, L., Incidence (1988–97) and prevalence (1997) of multiple sclerosis in Västerbotten County in northern Sweden. J Neurol Neurosurg Psychiatry 74 (2003), 29–32.
195. Sundström, P., Juto, G., Wadell, G., et al. An altered immune response to Epstein–Barr virus in multiple sclerosis: a prospective study. Neurology 62 (2004), 2277–2282.
196. Sundström, P., Nyström, L., Hallmans, G., Smoke exposure increases the risk for multiple sclerosis. Eur J Neurol 15 (2008), 579–583.
197. Swank, R.L., Multiple sclerosis: a correlation of its incidence with dietary fat. Am J Med Sci 220 (1950), 421–430.
198. Swank, R.L., A prospective discussion of past international nutrition catastrophes – indications for the future. Nutrition 13 (1997), 344–348.
199. Swank, R.L., Dugan, B.B., Viewpoint: effect of low saturated fat diet in early and late cases of multiple sclerosis. Lancet 336 (1990), 37–39.
200. Swank, R.L., Grimsgaard, A., Multiple sclerosis: the lipid relationship. Am J Clin Nutr 48 (1988), 1387–1393.
201. Swank, R.L., Lerstad, O., Strom, A., et al. Multiple sclerosis in rural Norway: its geographic and occupational incidence in relation to nutrition. N Engl J Med 264 (1952), 721–728.
202. Tavera-Mendoza, L.E., White, J.H., Cell defenses and the sunshine vitamin. Sci Am 97 (2007), 62–65 68–70, 72.
203. Templer, D.I., Trent, N.H., Spencer, D.A., et al. Season of birth in multiple sclerosis. Acta Neurol Scand 85 (1992), 107–109.
204. Teschke, K., Smith, J.C., Olshan, A.F., Evidence of recall bias in volunteered vs. prompted responses about occupational exposures. Am J Ind Med 38 (2000), 385–388.
205. Testi, M., Battarra, M., Lucarelli, G., et al. HLA-A-B-C-DRB1-DQB1 phased haplotypes in 124 Nigerian families indicate extreme HLA diversity and low linkage disequilibrium in Central-West Africa. Tissue Antigens 86 (2015), 285–292.
206. Thacker, E.L., Mirzaei, F., Ascherio, A., Infectious mononucleosis and risk for multiple sclerosis: a meta-analysis. Ann Neurol 59 (2006), 499–503.
207. Thorogood, M., Hannaford, P.C., The influence of oral contraceptives on the risk of multiple sclerosis. Br J Obstet Gynecol 105 (1998), 1296–1299.
208. Torkildsen, Ø., Aarseth, J., Benjaminsen, E., et al. Month of birth and risk of multiple sclerosis: confounding and adjustments. Ann Clin Transl Neurol 1 (2014), 141–144.
209. Trapp, B.D., Peterson, J.P., Ransohoff, R.M., et al. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 338 (1998), 278–285.
210. Tremlett, H., Paty, D., Devonshire, V., Disability progression in multiple sclerosis is slower than previously reported. Neurology 66 (2006), 172–177.
211. Trojano, M., Pellegrini, F., Fuiani, A., et al. New natural history of interferon-beta-treated relapsing multiple sclerosis. Ann Neurol 61 (2007), 300–306.
212. Van der Mei, I.A.F., Ponsonby, A.-L., Dwyer, T., et al. Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study. Br Med J 327 (2003), 316–322.
213. Vaughan, J.H., The Epstein–Barr virus in autoimmunity. Springer Semin Immunopathol 17 (1995), 203–230.
214. Villard-Macintosh, L., Vessey, M.P., Oral contraceptives and reproductive factors in multiple sclerosis incidence. Contraception 47 (1993), 161–168.
215. Vost, A., Wolochow, D., Howell, D., Incidence of infarcts of the brain in heart diseases. J Path Bact 88 (1964), 463–470.
216. Vukusic, S., Hutchinson, M., Hours, M., et al. Pregnancy and multiple sclerosis (the PRIMS study): clinical predictors of post-partum relapse. Brain 127 (2004), 1353–1360.
217. Wagner, H.J., Hennig, H., Jabs, W.J., et al. Altered prevalence and reactivity of anti-Epstein–Barr virus antibodies in patients with multiple sclerosis. Viral Immunol 13 (2000), 497–502.
218. Wechsler, I.S., Statistics of multiple sclerosis. Arch Neurol Psychiatry 8 (1922), 59–75.
219. Weinshenker, B.G., Bass, B., Rice, G.P.A., et al. The natural history of multiple sclerosis: a geographically based study: II. Predictive value of the early clinical course. Brain 112 (1989), 133–146.
220. Wennerström, A., Vlachopoulou, E., Lahetla, E., et al. Diversity of extended HLA-DRB1 haplotypes in the Finnish population. PLoS One, 8(11), 2013, e79690.
221. Wesnes, K., Riise, T., Casetta, I., et al. Body size and the risk of multiple sclerosis in Norway and Italy: the EnvIMS study. Mult Scler 21 (2015), 388–395.
222. Willer, C.J., Dyment, D.A., Risch, N.J., et al. Twin concordance and sibling recurrence rates in multiple sclerosis. Proc Natl Acad Sci U S A 100 (2003), 12877–12882.
223. Willer, C.J., Dyment, D.A., Sadovnick, A.D., et al. Timing of birth and risk of multiple sclerosis: population based study. Br Med J 330 (2005), 120–124.
224. Witte, J.S., Carlin, J.B., Hopper, J.L., Likelihood-based approach to estimating twin concordance for dichotomous traits. Genetic Epidemiol 16 (1999), 290–304.
225. Wynn, D.R., Rodriguez, M., O'Fallon, M., et al. A reappraisal of the epidemiology of multiple sclerosis in Olmsted County, Minnesota. Neurology 40 (1990), 780–786.
226. Yamasaki, R., Lu, H., Butovsky, O., et al. Differential roles of microglia and monocytes in the inflamed central nervous system. J Exp Med 211 (2014), 1533–1549.
227. Young, L.S., Yao, Q.Y., Rooney, C.M., et al. New type B isolates of Epstein–Barr virus from Burkitt's lymphoma and from normal individuals in endemic areas. J Gen Virol 68 (1987), 2853–2862.
228. Zimber, U., Adlinger, H.K., Lenoir, G.M., et al. Geographical prevalence of two types of Epstein–Barr virus. Virology 154 (1986), 56–66.
229. Zúñiga, J., Yu, N., Barqera, R., et al. HLA class I and class II conserved extended haplotypes and their fragments or blocks in Mexicans: implications for the study of genetic diversity in admixed populations. PLoS One, 8(9), 2013, e74442.